Available Forms: Tablets
Available Strengths: 50 mg, 100 mg, 200 mg
Reference Brands: Reyvow (USA)
Category: Neurology
Quick Response Guaranteed | Verified Suppliers
Product Description:
Lasmiditan is an oral medication used for the acute treatment of migraine attacks and is marketed under the brand name Reyvow. It is indicated for adults experiencing migraine with or without aura, providing rapid relief from headache pain and associated migraine symptoms. Lasmiditan is not used for migraine prevention and is intended solely for treatment at the onset of a migraine attack.
As a selective serotonin 5-HT<sub>1F</sub> receptor agonist, lasmiditan works by modulating specific pathways in the central nervous system involved in migraine pain without causing blood vessel constriction. This makes it a suitable option for patients who have cardiovascular risk factors and cannot take traditional triptan medications. Taken orally, lasmiditan provides a convenient and targeted approach for controlling migraine episodes, helping to reduce pain, sensory disturbances, and other migraine-related symptoms under medical supervision.
It represents an important addition to acute migraine therapy, offering relief through a mechanism distinct from vasoconstrictive migraine medications.
Lasmiditan is used for the acute treatment of migraine attacks with or without aura in adults.
Lasmiditan is a synthetically manufactured selective 5-HT<sub>1F</sub> receptor agonist designed to target migraine-related pain pathways without causing vasoconstriction.
The trade name of lasmiditan is Reyvow.
Reyvow is developed and marketed by Eli Lilly and Company.
The generic name of Lasmiditan is lasmiditan.
The brand name of Lasmiditan is Reyvow.
Lasmiditan oral tablets are manufactured in GMP-compliant pharmaceutical facilities, primarily in the USA.
Strength: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Ubrelvy (USA/India)
Strength: 100 mg
Reference Brands: Tasmar (USA/EU)
Strength: 50 mg ,100 mg
Reference Brands: Xadago (USA/EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under βFair use.β
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.
Online Β· B2B Pharma Β· Medical Tourism Β· NPP